Researchers from IBB-UAB have developed a second-generation molecule that significantly improves the stabilization and inhibition of the aggregation of proteins involved in Transthyretin Amyloidosis (ATTR), a group of minority ...
Oct 18, 2023
0
0
An international project lead by the Molecular and Cell Biology Institute of Porto University with the participation of researchers from IMIM (Hospital del Mar Medical Research Institute) has, for the first time ever, deciphered ...
Dec 11, 2012
0
0
(Medical Xpress)—A breakthrough study led by researchers at Royal Prince Alfred Hospital and the University of Sydney's Brain and Mind Research Institute (BMRI) has revealed how brain tumours communicate with other cells, ...
Jun 21, 2013
0
0
In a study published in Nature Communications, KI researchers have revealed a fascinating discovery that could be important in cancer treatments. This new insight involves c-MYC, a protein component that is central to cancer ...
Feb 29, 2024
0
0
A team of the Institute of Neurosciences of the University of Barcelona has participated in the design of the first light-activated drug, JF-NP-26, for the treatment of pain, according to a study with animal models published ...
Apr 12, 2017
0
12
Scientists are a step closer to developing vaccines for a range of diseases that affect 200 million people, mainly in tropical south-east Asia, Africa and Central America.
Mar 14, 2013
0
0
A novel study from the University of South Australia has identified a range of metabolic biomarkers that could help predict the risk of cancer.
Aug 31, 2023
0
2
Scientists from the Spanish National Cancer Research Centre's Structural Computational Biology Group, led by Alfonso Valencia, are making the largest ever catalogue of biological chimeras available to the public domain. Specifically, ...
Jan 29, 2015
0
7
Scientists at the University of Essex have made a further step towards the potential future development of medicines to help combat a range of diseases currently considered "undruggable".
Apr 30, 2013
0
0
Scientists have found that the anti-inflammatory molecule, IL-10, may improve success rates of skin autografts (skin moved from one site of the body to another). This information provides a valuable drug target that may benefit ...
Jul 31, 2012
0
0
